Pediatric Vaccines Market worth US $2.5Bn in 2019 with a CAGR of 7.00%
.gif)
An increasing number of chronic diseases with the increasing awareness of immunization is the major propelling factor for the growth of the global market. For instance, as per the WHO (World Health Organization) in 2019, the 182 countries reported 364,808 measles cases. Additionally, the technical advancement in the vaccines is another driving factor for the growth of the target market. Moreover, the rise in government and non- government funding in the R&D to develop the vaccines which are the boosting factor for the growth of the global market. The report " Global Pediatric Vaccines Market, By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, and Other Technologies), By Vaccine Type (Monovalent, and Multivalent), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Foreca...